U.S. settles 'pay-for-delay' fight with drugmaker Teva over Provigil

WASHINGTON (Reuters) - U.S. antitrust regulators have settled a long-running fight with Cephalon, now owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news